180 related articles for article (PubMed ID: 18424838)
21. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.
Mylonas I; Makovitzky J; Friese K; Jeschke U
Acta Histochem; 2009; 111(4):349-59. PubMed ID: 19195687
[TBL] [Abstract][Full Text] [Related]
22. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
23. BAG-1 expression in normal and neoplastic endometrium.
Moriyama T; Littell RD; Debernardo R; Oliva E; Lynch MP; Rueda BR; Duska LR
Gynecol Oncol; 2004 Aug; 94(2):289-95. PubMed ID: 15297164
[TBL] [Abstract][Full Text] [Related]
24. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
25. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
26. [An immunohistochemical study of the steroid hormone receptors in endometrial hyperplasia].
Teleman S; Hilgarth M; Freudenberg N; Bettendorf H; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):138-41. PubMed ID: 10756900
[TBL] [Abstract][Full Text] [Related]
27. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
Singh M; Zaino RJ; Filiaci VJ; Leslie KK
Gynecol Oncol; 2007 Aug; 106(2):325-33. PubMed ID: 17532033
[TBL] [Abstract][Full Text] [Related]
28. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
29. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.
Park JS; Jung WH; Kim JK; Hwang HK; Cho SI; Yoon DS; Chi HS; Kim BR
J Surg Res; 2009 Mar; 152(1):104-10. PubMed ID: 18394649
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical localization of the estrogen receptor alpha (ERalpha) and progesterone receptor (PR) in the uterus of sika deer (Cervus nippon) during pregnancy.
Yanagawa Y; Matsuura Y; Suzuki M; Katagiri S; Tsubota T
Jpn J Vet Res; 2008 Nov; 56(3):139-49. PubMed ID: 19177743
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
34. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
35. Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.
Nyholm HC; Christensen IJ; Nielsen AL
Gynecol Oncol; 1995 Dec; 59(3):347-51. PubMed ID: 8522253
[TBL] [Abstract][Full Text] [Related]
36. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
[TBL] [Abstract][Full Text] [Related]
37. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
Zang H; Sahlin L; Masironi B; Hirschberg AL
Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
[TBL] [Abstract][Full Text] [Related]
38. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
39. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
40. Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer.
De Cicco Nardone F; Rossiello F; Iacopino F; Benedetto MT; Cinque B; Dell'Acqua S; Sica G
Anticancer Res; 1996; 16(1):161-9. PubMed ID: 8615603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
